Quality by design (QbD) is becoming increasingly utilized as a valuable tool for focused and efficient drug development. Centering on case studies, we will look at how QbD can be used in its application to small molecules and biopharmaceuticals.
Florence Philippoz, Richard Dennett
2012 - STP Pharma Pratiques
Senior Director and Qualified Person
Florence Philippoz is responsible for the management of projects involving the development of Chemistry Manufacturing and Control (CMC). With a strong industrial experience in Quality Assurance, Quality Control and Analytical Development, Florence contributes actively in the elaboration of product development plans and participates in the preparation of supportive documents such as stability and validation reports, process optimization/development reports.
Richard Dennett, Director CMC & Quality
Richard is responsible for the management of projects involving the development of Chemistry Manufacturing and Control (CMC). He provides experienced scientific, Regulatory and Technical expertise for activities like CMC Product Development Strategy, Quality by Design (QbD), Technology Transfer, Comparability, cGMP compliance, Process Validation, Due Diligence, CMC Gap Analysis, Technical and Regulatory 'bridging', project management of cGMP outsourcing.